岳阳环宇药业有限公司 Company Information
Company Name:
Linxiang Huanyu Pharmaceutical Co., Ltd
Tel:
0730-3127188
Email:
Info@gfchemical.com
Nationality:
China
WebSite:
www.gfchemical.com
Product List:
64
1
Product List
Abiraterone
154229-19-3
4-CHLORODEHYDROMETHYLTESTOSTERONE
ZANAMIVIR HYDRATE
139110-80-8
Aceclofenac
89796-99-6
Metandienone
72-63-9
Carprofen
53716-49-7
CARAZOLOL HCL
57775-29-8
Ethisterone
434-03-7
Ethinyl Estradiol
57-63-6
Torasemide
56211-40-6
Losartan potassium
124750-99-8
Estriol
50-27-1
Busulfan
55-98-1
3,5-Diacetoxyacetophenone
35086-59-0
Azathioprine
446-86-6
β-estradiol
50-28-2
Epinastine
80012-43-7
Ethyl 2-(Chlorosulfonyl)acetate
55896-93-0
2-Chloro-1,4-naphthoquinone
1010-60-2
Dexamethasone 9,11-epoxide
24916-90-3
4-Chlorotestosterone acetate
855-19-6
17A hydroxyprogesterone acetate
17-Hydroxy-1a,2a-methylenepregna-4,6-diene-3,20-dione acetate
2701-50-0
4-(4-Chlorophenyl)cyclohexanecarboxylic acid
49708-81-8
Atropic acid
492-38-6
Phthalide
87-41-2
6-oxo saponin
Niflumic acid
4394-00-7
Lenalidomide
191732-72-6
Cyclopropanone acetate ring opener
1α-(Chloromethyl) Chlormadinone Acetate
17183-98-1
Androst-2-en-17-one
963-75-7
4,9-object
Progesterone
57-83-0
Androst-1-ene-3b-ol-17-one
7-Methoxyflavone
22395-22-8
Colorron
7alpha-Methyl-3,3-dimethoxy-5(10)-estrene-17-one
88247-84-1
Epistane
4267-80-5
6A-methylprednisolone
3-AMINO-1,2,4-BENZOTRIAZINE-1,4-DIOXIDE
27314-97-2
Megestrol
3562-63-8
Flunixin meglumine
42461-84-7
Estrone
53-16-7
Exemestane
107868-30-4
Rufinamide
106308-44-5
4-Chloro-3-pyridinesulfonamide
33263-43-3
Pregna-4,6-diene-3,20-dione
1162-56-7
Isotretinoin
4759-48-2
Formestane
566-48-3
Estradiol
Boldenone undecylenate
13103-34-9
9β,11β-Epoxy-17,21-dihydroxy-16β-methylpregna-1,4-diene-3,20-dione
981-34-0
Estradiol
57-91-0
Oxymetholone
434-07-1
Betamethasone
378-44-9
Bicalutamide
90357-06-5
Methenolone enanthate
303-42-4
Allylestrenol
432-60-0
Medroxyprogesterone Acetate
71-58-9
LUMIRACOXIB
Tibolone
5630-53-5
Chlormadinone acetate
302-22-7
Mesterolone
1424-00-6
1
Copyright 2007© ChemicalBook. All rights reserved.